Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2005-11-22
2005-11-22
Kemmerer, Elizabeth (Department: 1647)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C530S350000, C530S351000, C530S399000, C435S007100, C435S325000, C514S002600, C514S012200, C424S085100, C424S093700, C424S198100
Reexamination Certificate
active
06967029
ABSTRACT:
Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
REFERENCES:
patent: 3898837 (1975-08-01), Boege
patent: 4275056 (1981-06-01), Takaku et al.
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4353242 (1982-10-01), Harris et al.
patent: 4438032 (1984-03-01), Golde et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4695542 (1987-09-01), Yokota et al.
patent: 4703008 (1987-10-01), Lin
patent: 4714680 (1987-12-01), Civin
patent: 4721096 (1988-01-01), Naughton et al.
patent: 4722998 (1988-02-01), Cantor et al.
patent: 4808611 (1989-02-01), Cosman
patent: 4810643 (1989-03-01), Souza
patent: 4845078 (1989-07-01), Masaoka
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4877729 (1989-10-01), Clark et al.
patent: 4879227 (1989-11-01), Clark et al.
patent: 4959314 (1990-09-01), Mark et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4965204 (1990-10-01), Civin
patent: 5087570 (1992-02-01), Weissman et al.
patent: 5119315 (1992-06-01), Kemp et al.
patent: 5121337 (1992-06-01), Brown
patent: 5599703 (1997-02-01), Davis et al.
patent: 5620685 (1997-04-01), Nishi et al.
patent: 5641670 (1997-06-01), Treco et al.
patent: 5767074 (1998-06-01), Besmer et al.
patent: 5772992 (1998-06-01), Bauer et al.
patent: 5786323 (1998-07-01), Nakahata
patent: 5935565 (1999-08-01), Besmer et al.
patent: 6248319 (2001-06-01), Zsebo et al.
patent: 6403559 (2002-06-01), Besmer et al.
patent: 0 232 707 (1987-08-01), None
patent: 0 845 268 (1998-06-01), None
patent: 62-223126 (1987-10-01), None
patent: 8325294 (1996-12-01), None
patent: 62-107796 (1997-05-01), None
patent: 09154578 (1997-06-01), None
patent: WO 89/04452 (1989-05-01), None
patent: WO 92/03459 (1992-03-01), None
patent: WO 92/07074 (1992-04-01), None
patent: WO 93/21936 (1993-11-01), None
patent: WO 95/06112 (1995-03-01), None
patent: WO 95/28479 (1995-10-01), None
patent: WO 98/18924 (1998-05-01), None
patent: WO 98/23773 (1998-06-01), None
Groopman et al. Hematopoietic growth factors New England J Med 321(21): 1449-1459, 1989.
Broxmeyer et al. Human umbilical cord blood as potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86: 3828-3832, 1989.
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.
Wells, J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.
Brugger et al. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, IL-1B, IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81(10):2579-2584, 1993.
Bodine et al., “Combination of Interleukins 3 and 6 Preserves Stem Cell Function in Culture and Enhances Retrovirus-Mediated Gene Transfer Into Hematopoietic Stem Cells,”Proc. Nat'l Acad. Sci., USA,86:8897-8901 (1989).
Boswell et al., “A Novel Mast Cell Growth Factor (MCGF-3) Produced by Marrow-adherent Cells that Synergizes with Interleukin 3 and Interleukin 4,” Exp. Hematol., 18:794-800 (1990).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science,247:1306-1310 (1990).
Broxmeyer et al., “Cell-Free Granulocyte Colony Inhibiting Activity Derived from Human Polymorphonuclear Neutrophils,”Exp. Hemat.,5:87-102 (1977).
Dexter, T.M., “Haemopoietic Growth Factors,” I, 45(2):337-349 (1989).
Dick et al., “Introduction of New Genes into Hematopoietic Stem Cells,”J. Cell. Biol., Supplement 11A, p. 187 (1987) (Abstract D 026).
Dick et al., “Introduction of Selectable Gene into Primitive Stem Cells Capable of Long-Term Reconstitution of the Hemopoietic System of W/WvMice,”Cell,42:71-79 (1985).
Frömmel et al., “An Estimate of the Effect of Point Mutation and Natural Selection on the Rate of Amino acid Replacement in Proteins,”J. Mol. Evol.,21:233-257 (1985).
Fung et al., “Molecular cloning of cDNA for murine interleukin-3,”Nature,307:233-237 (1984).
Gough et al., “Molecular Cloning of cDNA Encoding a Murine Haematopoietic Growth Regulator, Granulocyte-Macrophage Colony Stimulating Factor,”Nature,309:763-767 (1984).
Grabbe, J. et al., “Stem Cell Factor, a Novel Cutaneous Growth Factor for Mast Cells and Melanocytes,”Arch. Dermatol. Res.,287:78-84 (1994).
Grichnik, J.M. et al., “The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte Homeostasis,”J. Invest. Dermatol.,111:233-238 (1998).
Hiraoka et al., “Further Characterization of the Biological Properties of Human Hematopoietic Survival and Growth Factor,”Expl. Cell. Biol.,57:27-34 (1989).
Hiraoka et al., “Production of Human Hematopoietic Survival and Growth Factor by a Myeloid Leukemia Cell Line (KPB-M15) and Placenta as Detected by a Monoclonal Antibody,”Cancer Research,47:5025-5030 (1987).
Hiraoka et al., “Human Hematopoietic Survival and Growth Factor,”Cell Biology International Reports,10(5):347-355 (1986).
Hiraoka et al., “Monoclonal Antibodies Against Human Hematopoietic Survival and Growth Factor,”Biomed. Biochim. Acta,46(5):419-427 (1987).
Hiraoka et al., “In Vitro Effect of Murine Peritoneal Exudate Cells Activated with a Streptococcal Preparation, OK-432, on Hematopoietic Stem Cells,”ACTA Hematol. Japan,45:82-90.
Hiraoka et al., Cancer Research, 47(19):5025-5030 (1987); Abstract.
Hollands, “Differentiation of Embryonic Haemopoietic Stem Cells from Mouse Blastocysts Growth in Vitro,”Development,102:135-141 (1988).
Humphries et al., “Aplastic Anemia and Stem Cell Biology,” inAplastic Anemia: Stem Cell Biology and Advances in Treatment,Alan R. Liss, Inc., New York, New York, pp. 3-12 (1984).
Jones et al., “Cyclic Hematopoiesis: Animal Models,”Exp. Hematol.,11:571-580 (1983).
Kamamoto et al., “Establishment of Two Ph1Chromosome-Positive Cell Lines, KPB-M8 and KPB-M15,”Jpn. J. Clin. Oncol.,16:107-115 (1986).
Kawasaki et al., “Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1),”Science,230:291-296 (1985).
King, R.C. et al., in A Dictionary of Genetics, Fifth Edition, Oxford University Press, p. 138 (Nov., 1996).
Kriegler et al., “Sources of Murine Macrophage Colony-Stimulating Factor that also Contain Growth Factors for Primitive Macrophage Progenitor Cells,”Exp. Hematol.,12:844-849 (1984).
Kriegler et al., “Partial Purification and Characterization of a Growth Factor for Macrophage Progenitor Cells with High Proliferative Potential in Mouse Bone Marrow,”Blood,60:503-508 (1982).
Langley et al., “Soluble Stem Cell Factor in Human Serum,”Blood,81(3):656-660 (1993).
Lee et al., “Isolation of cDNA for a Human Granulocyte-Macrophage Colony-Stimulating Factor by Functional Expression in Mammalian Cells,”Proc. Natl. Acad. Sci., USA,82:4360-4364 (1985).
Lev, S. et al., “Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction,” Critical Reviews in Oncogenesis
Bosselman Robert A.
Martin Francis H.
Suggs Sidney V.
Zsebo Krisztina M.
Amgen Inc.
Bunner Bridget E.
Kemmerer Elizabeth
Marshall & Gerstein & Borun LLP
LandOfFree
Method for increasing hematopoietic progenitor cells by stem... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for increasing hematopoietic progenitor cells by stem..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing hematopoietic progenitor cells by stem... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3454000